These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22071129)

  • 41. FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.
    Parmera JB; Coutinho AM; Aranha MR; Studart-Neto A; de Godoi Carneiro C; de Almeida IJ; Fontoura Solla DJ; Ono CR; Barbosa ER; Nitrini R; Buchpiguel CA; Brucki SMD
    Mov Disord; 2021 Mar; 36(3):651-661. PubMed ID: 33206389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Zeng F; Goodman MM
    Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
    Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
    Nordberg A; Carter SF; Rinne J; Drzezga A; Brooks DJ; Vandenberghe R; Perani D; Forsberg A; Långström B; Scheinin N; Karrasch M; Någren K; Grimmer T; Miederer I; Edison P; Okello A; Van Laere K; Nelissen N; Vandenbulcke M; Garibotto V; Almkvist O; Kalbe E; Hinz R; Herholz K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):104-14. PubMed ID: 22961445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.
    Kitajima K; Abe K; Takeda M; Yoshikawa H; Ohigashi M; Osugi K; Koyama H; Yamakado K
    Medicine (Baltimore); 2021 Jan; 100(3):e23969. PubMed ID: 33545981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.
    Burack MA; Hartlein J; Flores HP; Taylor-Reinwald L; Perlmutter JS; Cairns NJ
    Neurology; 2010 Jan; 74(1):77-84. PubMed ID: 20038776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
    J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo amyloid imaging with PET in frontotemporal dementia.
    Engler H; Santillo AF; Wang SX; Lindau M; Savitcheva I; Nordberg A; Lannfelt L; Långström B; Kilander L
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):100-6. PubMed ID: 17846768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
    Frings L; Hellwig S; Bormann T; Spehl TS; Buchert R; Meyer PT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1442-1448. PubMed ID: 29546632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The correlation between striatal and cortical binding ratio of
    Sauerbeck J; Ishii K; Hosokawa C; Kaida H; Scheiwein FT; Hanaoka K; Rominger A; Brendel M; Bartenstein P; Murakami T
    Ann Nucl Med; 2018 Jul; 32(6):398-403. PubMed ID: 29730823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Amyloid PET in Alzheimer research].
    Ishii K
    Brain Nerve; 2010 Jul; 62(7):757-67. PubMed ID: 20675880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amyloid imaging.
    Villemagne VL; Rowe CC
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S41-9. PubMed ID: 21729418
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.